Local biotech, academics eyeing $5.5 billion stem cell measure
As California ’s stem cell research agency prepares to seek another $5.5 billion from taxpayers, local biotech researchers and companies are keeping a close eye on where those dollars go.
The California Institute for Regenerative Medicine was founded in 2004 after voters approved a $3 billion bond issue to f und stem cell research and commercialization across the state. As the agency’s funding is expected to run out this year, backers have proposed a measure for another $5.5 billion bond that…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Felicia Alvarez Source Type: news
More News: Biotechnology | Funding | Health Management | Pharmaceuticals | Stem Cell Therapy | Stem Cells | Tax